rhein has been researched along with 2019 Novel Coronavirus Disease in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, B; Huo, X; Ma, X; Sun, C; Tian, X; Wang, Y; Wu, F; Zhang, B; Zhang, Y; Zhao, T | 1 |
| Chen, Q; Fang, B; Feng, L; Huo, X; Lv, X; Ma, X; Mei, Q; Sun, C; Tian, X; Wang, C; Wang, Y; Wu, F; Zhang, Y | 1 |
| Chen, Y; Huan, S; Ouyang, Y; Shang, J; Sun, S; Wang, X; Xiong, B; Zhang, XB | 1 |
| Aretz, O; Bergrath, S; Deussen, M; Hohn, A; Lahm, A; Reith, T; Strapatsas, T; Tuemen, M | 1 |
| Cooper, C; Harvey, NC; Raisi-Estabragh, Z | 1 |
5 other study(ies) available for rhein and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Simultaneous Determination of Ten Active Components From Jinhongtang Granule in Rat Plasma by LC-MS/MS and its Application to a Comparative Pharmacokinetic Study in Normal and Sepsis Rats In Vivo and In Vitro.
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; COVID-19; Drugs, Chinese Herbal; Glucosides; Rats; Reproducibility of Results; Sepsis; Tandem Mass Spectrometry | 2023 |
UGTs-mediated metabolic interactions contribute to enhanced anti-inflammation activity of Jinhongtang.
Topics: Animals; Anti-Inflammatory Agents; COVID-19; Emodin; Humans; Lipopolysaccharides; Mice; Rats; Sepsis | 2023 |
Virus-like Plasmonic Nanoprobes for Quick Analysis of Antiviral Efficacy and Mutation-Induced Drug Resistance.
Topics: Antiviral Agents; Ceftazidime; COVID-19; Gold; Humans; Metal Nanoparticles; Mutant Proteins; Mutation; Protein Binding; SARS-CoV-2 | 2023 |
Impact of the COVID-19 pandemic on emergency medical resources : An observational multicenter study including all hospitals in a major urban center of the Rhein-Ruhr metropolitan region.
Topics: COVID-19; Emergency Service, Hospital; Hospitalization; Hospitals; Humans; Pandemics | 2022 |
Vitamin D supplementation and COVID-19 disease: safety but unproven efficacy-reply to Dr Helga Rhein.
Topics: Anthraquinones; COVID-19; Dietary Supplements; Humans; SARS-CoV-2; Vitamin D | 2021 |